Humanigen, Inc
HGENDelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001293310
Humanigen, Inc was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Oct 20, 2023; 38 institutions reported holding it in 13F filings for Q2 2023, worth $839.7K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Humanigen, Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 42 | 38 | −4 |
| Shares | 4.67M | 5.51M | +838.5K (+17.9%) |
| Value | $669.0K | $839.7K | +$170.7K (+25.5%) |
New holders (2)
Institutions that held Humanigen, Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Csenge Advisory Group | 39,250 | $5.98K | 0.00% |
| Daymark Wealth Partners, LLC | 12,500 | $1.91K | 0.00% |
Sold out (6)
Institutions that held Humanigen, Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| JustInvest LLC | 17,703 | $2.54K |
| Wealth Alliance Advisory Group, LLC | 15,000 | $2.15K |
| Millennium Management LLC | 16,989 | $2.00K |
| Susquehanna International Group, LLP | 13,768 | $1.98K |
| Raymond James & Associates | 10,300 | $1.48K |
| Gradient Investments LLC | 1,000 | $144 |